Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Asia Pacific Prostate Cancer Conference /
Lecture: Clinical Perspectives: How far are we from personalising treatment for prostate cancer patients?

1st - 2nd Mar 2014

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 12.05.14
Views: 2615

Dr Paul de Souza - University of Western Sydney, New South Wales, Australia

Dr Paul de Souza from New South Wales, Australia, discusses how close we are to personalising treatment in patients with prostate cancer. He explores what the concept of personalised medicine really means, and the biomarkers being considered in prostate cancer in this regard. He explores the process for biomarker development, and also notes the challenges of personalised care in prostate cancer.

This video is sponsored by an educational grant from Janssen Asia Pacific, a pharmaceutical company of Johnson & Johnson

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation